UPDATE: BofA Securities Upgrades Moderna (MRNA) to Neutral
Tweet Send to a Friend
(Updated - January 21, 2022 6:50 AM EST)
BofA Securities analyst Geoff Meacham upgraded Moderna (NASDAQ: MRNA) from Underperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Geoff Meacham upgraded Moderna (NASDAQ: MRNA) from Underperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
